XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/bayer-shakes-up-rd-unit-as-busch-is-on-his-way-out/20%Monthly2017-11-30 20:05
https://biotechstocks.com/gt-biopharma-inc-gtbp-to-present-data-on-next-generation-trike-oxs-c3550/20%Monthly2018-06-06 17:53
https://biotechstocks.com/codiak-completes-77m-raise-to-for-trials-on-exosome-enabled-therapies/20%Monthly2017-11-29 20:12
https://biotechstocks.com/studies-show-stress-could-be-affecting-the-bodys-response-to-cancer-treatments/20%Monthly2017-11-29 20:10
https://biotechstocks.com/peregrine-pharmaceuticals-inc-pphm-announces-appointment-of-tracy-kinjerski-as-vice-president-of-business-operations/20%Monthly2017-11-29 13:41
https://biotechstocks.com/bluebird-bio-inc-blue-acquires-manufacturing-facility-in-north-carolina/20%Monthly2017-11-29 13:39
https://biotechstocks.com/biohaven-puts-best-foot-forward-for-oral-migraine-treatment/20%Monthly2017-11-28 20:27
https://biotechstocks.com/auris-medical-affected-by-another-late-stage-trial-failure/20%Monthly2017-11-28 20:05
https://biotechstocks.com/oncosec-medical-incorporated-oncs-announces-issuance-of-patents-for-immunopulse-platform/20%Monthly2017-11-28 13:51
https://biotechstocks.com/biogen-completes-deal-to-defend-ms-territory/20%Monthly2017-11-27 20:22
https://biotechstocks.com/merck-wages-1b-euro-on-rd-in-post-brexit/20%Monthly2017-11-27 20:20
https://biotechstocks.com/medovex-corporation-mdvx-submits-ide-with-the-food-and-drug-administration-for-its-denervex-system/20%Monthly2017-11-27 13:37
https://biotechstocks.com/corbus-pharmaceuticals-holdings-inc-crbp-expands-intellectual-property-portfolio/20%Monthly2017-11-27 13:33
https://biotechstocks.com/another-biotech-byproduct-of-takeda/20%Monthly2017-11-24 17:46
https://biotechstocks.com/medtronic-eases-in-q2-but-anticipates-growth-to-rebound/20%Monthly2017-11-24 17:34
https://biotechstocks.com/possible-new-design-for-development-of-hiv-vaccine/20%Monthly2017-11-22 20:52
https://biotechstocks.com/fda-permits-prescient-to-resume-lead-drug-trial/20%Monthly2017-11-22 20:48
https://biotechstocks.com/do-you-know-the-secret-to-a-better-concussion-diagnosis/20%Monthly2017-11-21 20:52
https://biotechstocks.com/cytokinetics-says-goodbye-to-phase-3-als-drug/20%Monthly2017-11-21 20:48
https://biotechstocks.com/dbvs-stock-increases-on-positive-safety-report/20%Monthly2017-11-20 20:52
https://biotechstocks.com/acorda-loses-363m-on-parkinsons-drug/20%Monthly2017-11-20 20:31
https://biotechstocks.com/the-fda-green-lights-new-treatment-for-rare-genetic-enzyme-disorder/20%Monthly2017-11-17 20:12
https://biotechstocks.com/top-25-biotech-stocks-of-2017/20%Monthly2017-11-17 20:56
https://biotechstocks.com/cue-biopharma-enters-374m-immunotherapy-agreement/20%Monthly2017-11-16 20:20
https://biotechstocks.com/alnylam-begins-rolling-fda-filing-for-therapeutic/20%Monthly2017-11-17 19:13
https://biotechstocks.com/bluebird-bio-inc-blue-announces-first-patient-treated-in-northstar-3-hgb-212-phase-3-study-of-lentiglobin/20%Monthly2017-11-16 13:25
https://biotechstocks.com/gt-biopharma-inc-gtbp-announces-shawn-m-as-president-and-chief-operating-officer/20%Monthly2018-06-06 17:53
https://biotechstocks.com/quotient-changes-identity-after-new-acquisition/20%Monthly2017-11-16 13:44
https://biotechstocks.com/acorda-therapeutics-fails-on-safety-fears-for-tozadenant-parkinsons-drug/20%Monthly2017-11-15 19:23
https://biotechstocks.com/corbus-pharmaceuticals-holdings-inc-crbp-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference/20%Monthly2017-11-15 13:53
https://biotechstocks.com/halozyme-therapeutics-inc-halo-to-participate-in-upcoming-healthcare-conferences/20%Monthly2017-11-15 13:51
https://biotechstocks.com/medovex-corp-mdvx-initiates-move-to-list-on-the-otcqb-market/20%Monthly2017-11-15 13:42
https://biotechstocks.com/bayer-dishes-out-400m-upfront-to-acquire-interest-in-loxo-cancer-drugs/20%Monthly2017-11-14 20:54
https://biotechstocks.com/locus-secures-19m-series-a-round-to-take-crispr-antimicrobial-drug-to-clinical-trials/20%Monthly2017-11-14 20:51
https://biotechstocks.com/pluristem-therapeutics-inc-psti-first-quarter-fiscal-2018-corporate-and-financial-highlights5667/20%Monthly2017-11-14 13:52
https://biotechstocks.com/bill-gates-commits-to-50m-to-battle-alzeheimers/20%Monthly2017-11-13 20:03
https://biotechstocks.com/novartis-adds-to-gene-therapy-rd-portfolio/20%Monthly2017-11-13 18:41
https://biotechstocks.com/medovex-corp-mdvx-partners-with-russo-to-highlight-medical-technology-innovation/20%Monthly2017-11-13 13:17
https://biotechstocks.com/neuralstem-inc-cur-reports-third-quarter-2017-fiscal-results-and-provides-clinical-and-business-update/20%Monthly2017-11-13 13:08
https://biotechstocks.com/otonomys-renaissance-begins-as-menieres-disease-drug-passes-trial/20%Monthly2017-11-10 20:32
https://biotechstocks.com/editas-supporter-partners-calls-on-lilly-to-raise-171m-fund/20%Monthly2017-11-10 20:29
https://biotechstocks.com/halozyme-therapeutics-inc-halo-to-present-nonclinical-data-at-sitc-2017/20%Monthly2017-11-10 13:50
https://biotechstocks.com/oncosec-medical-inc-oncs-reports-positive-updated-follow-up-data-from-phase-2-trial/20%Monthly2017-11-10 13:46
https://biotechstocks.com/amgen-amgn-receives-positive-chmp-opinion-to-expand-use-of-nplate/20%Monthly2017-11-10 13:41
https://biotechstocks.com/sanofi-commits-to-805-million-for-preclinical-ms-drug-after-paying-40m/20%Monthly2017-11-09 20:26
https://biotechstocks.com/sage-therapeutics-ppd-treatment-reaches-phase-3-trial-goals/20%Monthly2017-11-09 20:06
https://biotechstocks.com/oncosec-medical-incorporated-oncs-announces-preclinical-data-demonstrating-multi-gene-expression-platform/20%Monthly2017-11-09 13:33
https://biotechstocks.com/alcobra-ltd-adhd-third-quarter-2017-financial-results-and-provides-corporate-update/20%Monthly2017-11-09 13:30
https://biotechstocks.com/ex-roche-calico-executive-takes-cso-role-at-gsk/20%Monthly2017-11-08 20:33
https://biotechstocks.com/specific-treatments-for-traumatic-brain-injury-patients/20%Monthly2017-11-08 20:25
https://biotechstocks.com/corbus-pharmaceuticals-holdings-inc-crbp-reports-2017-third-quarter-financial-results-and-highlights-recent-corporate-and-clinical-advancements/20%Monthly2017-11-08 14:05
https://biotechstocks.com/neuralstem-inc-cur-strengthens-executive-leadership-team-with-appointment-of-dr-david-recker-as-chief-medical-officer/20%Monthly2017-11-08 14:02
https://biotechstocks.com/oncosec-medical-incorporated-oncs-announces-positive-updated-long-term-follow-up-data-from-phase-2-trial-of-immunopulse-il-12/20%Monthly2017-11-08 13:59
https://biotechstocks.com/two-potential-key-drivers-for-biotech-stocks/20%Monthly2017-11-07 20:16
https://biotechstocks.com/eoc-completes-round-of-32m-to-continue-with-cancer-drugs/20%Monthly2017-11-07 19:51
https://biotechstocks.com/regeneron-pharmaceuticals-inc-regn-to-present-new-analyses-from-the-praluent-alirocumab-injection-odyssey-clinical-trial-program/20%Monthly2017-11-07 13:42
https://biotechstocks.com/conatus-pharmaceuticals-inc-cnat-to-present-at-stifel-healthcare-conference/20%Monthly2017-11-07 13:39
https://biotechstocks.com/can-gene-editing-be-the-solution-for-cancer-treatment/20%Monthly2017-11-06 20:46
https://biotechstocks.com/republican-tax-reforms-could-affect-rare-disease-rd/20%Monthly2017-11-06 19:40
https://biotechstocks.com/exicure-bags-over-11m-in-cash-for-psoriasis-closing-in-on-clinical-trials/20%Monthly2017-11-06 18:48
https://biotechstocks.com/medical-incorporated-oncs-fye-financial-review-analysts-target-and-upcoming-sitc-presentation/20%Monthly2017-11-06 14:09
https://biotechstocks.com/therapeutics-inc-psti-enters-into-agreement-with-tel-aviv-sourasky-medical-center/20%Monthly2017-11-06 14:05
https://biotechstocks.com/agios-investors-disappointed-with-data-on-leukemia-drug-ivosidenib/20%Monthly2017-11-03 19:54
https://biotechstocks.com/vedanta-increases-immuno-oncology-rd-with-focus-on-microbiome-pact/20%Monthly2017-11-03 19:48
https://biotechstocks.com/boehringer-and-dicerna-201m-agreement-to-treat-nash/20%Monthly2017-11-02 19:23
https://biotechstocks.com/new-york-vc-firm-raises-280m-for-life-science-companies/20%Monthly2017-11-02 19:21
https://biotechstocks.com/arcturus-therapeutics-inc-adhd-therapeutics-to-host-key-opinion-leader-call/20%Monthly2017-11-06 14:09
https://biotechstocks.com/cytori-therapeutics-inc-cytx-to-webcast-third-quarter-financial-results-on-november-9/20%Monthly2017-11-02 12:52
https://biotechstocks.com/vbi-vaccines-inc-vbiv-strengthens-board-of-directors-with-appointment-of-ran-nussbaum/20%Monthly2017-11-02 12:45
https://biotechstocks.com/biogen-biib-presents-new-data-from-long-term-extension-of-phase-1b-study/20%Monthly2017-11-02 12:33
https://biotechstocks.com/frazier-healthcare-partners-raises-419m-for-early-stage-biotech-startups/20%Monthly2017-11-01 13:20
https://biotechstocks.com/regeneron-pharmaceuticals-inc-regn-to-share-clinical-progress-of-regn1979-and-cemiplimab-regn2810/20%Monthly2017-11-01 13:17
https://biotechstocks.com/advaxis-inc-adxs-receive-4-5-million-through-the-new-jersey-economic-development-authority-nol-program/20%Monthly2017-11-01 13:15
https://biotechstocks.com/alder-biopharmaceuticals-inc-aldr-to-present-at-26th-annual-credit-suisse-healthcare-conference/20%Monthly2017-11-01 13:10
https://biotechstocks.com/bluebird-bio-inc-blue-to-present-new-data-from-clinical-studies/20%Monthly2017-11-01 13:13
https://biotechstocks.com/sanofi-cuts-voyagers-phase-%e2%85%94-parkinsons-gene-treatment-2/20%Monthly2017-11-01 12:54
https://biotechstocks.com/sanofi-cuts-voyagers-phase-%e2%85%94-parkinsons-gene-treatment/20%Monthly2017-11-01 12:48